Sekiya Tetsuji, Holley Matthew C
Department of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Neurological Surgery, Hikone Chuo Hospital, Hikone, Japan.
Cell Transplant. 2025 Jan-Dec;34:9636897251315271. doi: 10.1177/09636897251315271. Epub 2025 Mar 28.
Although notable progress has been made, restoring motor function from the brain to the muscles continues to be a substantial clinical challenge in motor neuron diseases/disorders such as spinal cord injury (SCI). While cell transplantation has been widely explored as a potential therapeutic method for reconstructing functional motor pathways, there remains considerable opportunity for enhancing its therapeutic effectiveness. We reviewed studies on motor pathway regeneration to identify molecular and ultrastructural cues that could enhance the efficacy of cell transplantation. While the glial scar is often cited as an intractable barrier to axon regeneration, this mainly applies to axons trying to penetrate its "core" to reach the opposite side. However, the glial scar exhibits a "duality," with an anti-regenerative core and a pro-regenerative "surface." This surface permissiveness is attributed to pro-regenerative molecules, such as laminin in the basement membrane (BM). Transplanting donor cells onto the BM, which forms plastically after injury, may significantly enhance the efficacy of cell transplantation. Specifically, forming detour pathways between transplanted cells and endogenous propriospinal neurons on the pro-regenerative BM may efficiently bypass the intractable scar core and promote motor pathway regeneration. We believe harnessing the tissue's innate repair capacity is crucial, and targeting post-injury plasticity in astrocytes and Schwann cells, especially those associated with the BM that has predominantly been overlooked in the field of SCI research, can advance motor system restoration to a new stage. A shift in cell delivery routes-from the traditional intra-parenchymal (InP) route to the transplantation of donor cells onto the pro-regenerative BM via the extra-parenchymal (ExP) route-may signify a transformative step forward in neuro-regeneration research. Practically, however, the complementary use of both InP and ExP methods may offer the most substantial benefit for restoring motor pathways. We aim for this review to deepen the understanding of cell transplantation and provide a framework for evaluating the efficacy of this therapeutic modality in comparison to others.
尽管已取得显著进展,但在脊髓损伤(SCI)等运动神经元疾病/障碍中,恢复从大脑到肌肉的运动功能仍然是一项重大的临床挑战。虽然细胞移植作为重建功能性运动通路的一种潜在治疗方法已得到广泛探索,但提高其治疗效果仍有很大空间。我们回顾了关于运动通路再生的研究,以确定能够提高细胞移植疗效的分子和超微结构线索。虽然神经胶质瘢痕常被视为轴突再生的顽固障碍,但这主要适用于试图穿透其“核心”到达对侧的轴突。然而,神经胶质瘢痕具有“双重性”,有一个抗再生的核心和一个促再生的“表面”。这种表面的允许性归因于促再生分子,如基底膜(BM)中的层粘连蛋白。将供体细胞移植到损伤后可塑性形成的BM上,可能会显著提高细胞移植的疗效。具体而言,在促再生的BM上,在移植细胞和内源性脊髓固有神经元之间形成迂回通路,可能有效地绕过顽固的瘢痕核心并促进运动通路再生。我们认为,利用组织的固有修复能力至关重要,针对星形胶质细胞和雪旺细胞损伤后的可塑性,尤其是那些与SCI研究领域中主要被忽视的BM相关的可塑性进行靶向治疗,可将运动系统恢复推进到一个新阶段。细胞递送途径从传统的脑实质内(InP)途径转变为通过脑实质外(ExP)途径将供体细胞移植到促再生的BM上,可能标志着神经再生研究向前迈出了变革性的一步。然而,实际上,InP和ExP方法的互补使用可能为恢复运动通路带来最大益处。我们旨在通过这篇综述加深对细胞移植的理解,并提供一个框架,用于与其他治疗方式相比评估这种治疗方式的疗效。